Skip to main content

Closed

ICCC: ImmuCell Corporation Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

88thpctl

Volume

0.33×avg

Market Cap

101.41MUSD

P/E Ratio

-187.5TTM

Div Yield

-ann

ImmuCell Corporation

ICCCNASDAQ Capital Market·USD·Closed

ImmuCell Corporation

ICCCNASDAQ·USD·Closed

$11.21

+1.36%

$11.21

+$0.15 (1.36%)

52W Range

88thpctl

Volume

0.33×avg

Mkt Cap

101.41MUSD

P/E

-187.5TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings